Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials (Q47688852)

22 February 2018

title

Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials (English)

1 reference

22 February 2018

amyotrophic lateral sclerosis

main subject

0 references

author

Leonard H van den Berg

6

object named as

Leonard H van den Berg

1 reference

22 February 2018

5

Jan H Veldink

1 reference

22 February 2018

Ruben P A van Eijk

1

1 reference

22 February 2018

Marinus J C Eijkemans

2

1 reference

22 February 2018

Toby A Ferguson

3

1 reference

22 February 2018

Stavros Nikolakopoulos

4

1 reference

22 February 2018

language of work or name

English

0 references

publication date

30 October 2017

1 reference

22 February 2018

Journal of Neurology, Neurosurgery and Psychiatry

published in

1 reference

22 February 2018

volume

89

1 reference

22 February 2018

issue

2

1 reference

22 February 2018

page(s)

156-161

1 reference

22 February 2018

Quantitative strength testing in ALS clinical trials

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

The PRO-ACT database: design, initial analyses, and predictive features

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Study designs and statistical analyses for biomarker research

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Biochemical alterations associated with ALS.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Statistical evaluation of biomarkers as surrogate endpoints: a literature review

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Total plasma creatinine: an accurate measure of total striated muscle mass

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5800333

Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29084868

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

ALSFRS-R score and its ratio: a useful predictor for ALS-progression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29084868

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JNNP-2017-317077

1 reference

22 February 2018

release_dq6uyhq3knhcjgn5te7lfqmpj4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dq6uyhq3knhcjgn5te7lfqmpj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

5800333

1 reference

22 February 2018

PubMed ID

29084868

1 reference

22 February 2018